Centenial Surgical Suture Ltd has scheduled its 31st Annual General Meeting (e-AGM) via video conferencing on Monday, September 28, 2026, at 2:00 pm, to transact ordinary and special business for FY26.

Key agenda items

The meeting will cover two categories of business. Under ordinary business, members will consider adopting the audited accounts for the year ended March 31, 2026, and the re-appointment of Anuradha Kashikar, Executive Director (DIN: 00804831), who retires by rotation. Under special business, members will vote on her re-appointment as Executive Director for a further term of three years from April 1, 2027 to March 31, 2030, with NIL remuneration.

Director profile: Anuradha Kashikar

Anuradha Kashikar, aged 65 years, holds a Bachelor of Commerce (B.Com) and a Bachelor of Law (LLB) from the University of Mumbai. She has served as Executive Director and Chief Financial Officer of the company since March 27, 2015, and is primarily responsible for managing the financial risks of the company as well as financial planning and record-keeping. She holds 6,98,500 equity shares in the company. She is the spouse of Vijay Majrekar, Managing Director of the company. Her current term expires on March 31, 2027.

The Board of Directors, at its meeting held on August 14, 2026, approved her re-appointment based on the recommendation of the Nomination and Remuneration Committee, subject to shareholder approval at the 31st AGM.

E-voting and record date

The company has engaged Purva Shareregistry (India) Private Limited as the authorised e-voting agency. Key dates for the e-voting process are as follows:

Members holding shares as of the cut-off date of September 21, 2026 are eligible to vote. The VC facility will be available to at least 1,000 members on a first-come-first-served basis, excluding large shareholders holding 2% or more, promoters, institutional investors, directors, and key managerial personnel, who may attend without restriction.

Access and participation

The notice of the 31st e-AGM and the Integrated Annual Report for FY26 are being sent electronically to members whose email addresses are registered with the company or depositories, in accordance with the relevant MCA and SEBI circulars. Members who wish to obtain a physical copy of the Annual Report may write to the company at shareinvestor@centenialindia.com . The AGM notice is also available on the company's website and on the BSE Limited website.

Centenial Surgical Suture Ltd Centenial Surgical Suture Ltd returned to profitability in the first quarter of FY26, reporting a standalone net profit of ₹73.59 lakh for the period ended June 30, 2026. This marks a significant turnaround from the net loss of ₹3.99 lakh incurred during the same quarter in the previous fiscal year.

The company’s total income from operations expanded by 18.7% year-on-year to ₹1,535.53 lakh, up from ₹1,293.80 lakh in Q1FY25. The improvement in the top line contributed to a pre-tax profit of ₹98.23 lakh, compared to a pre-tax loss of ₹3.99 lakh in the corresponding quarter of FY25.

Financial Performance

The Board of Directors approved the unaudited standalone financial results in its meeting held on August 14, 2026. The results were reviewed and recommended by the Audit Committee prior to board approval.

For the full year ended March 31, 2026, the company reported a net loss of ₹220.46 lakh, down from a loss of ₹208.33 lakh in Q4FY26 alone. The equity share capital remained unchanged at ₹364.83 lakh.

What the Numbers Show

The shift from a net loss to a net profit in Q1FY26 indicates an operational recovery for Centenial Surgical Suture. With total income rising nearly 19% while moving to a positive bottom line, the company appears to have improved its cost efficiency or product mix compared to the prior year period. The basic earnings per share turned positive at ₹2.09, reflecting the return to profitability for shareholders after a negative EPS of ₹0.19 in Q1FY25.